# Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation

> **NCT02683889** · PHASE3 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 15 (actual)

## Conditions studied

- FSGS

## Interventions

- **DRUG:** Acthar

## Key facts

- **NCT ID:** NCT02683889
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2024-06-06
- **Final completion:** 2024-06-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02683889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02683889, "Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02683889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*